Physician profile
Sameera Rahman
NPI 1205067378
$894.13
in general payments reported to CMS, 2019-2025
15 companies · $19.79 in 2025
The $19.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2022: $478 · 2023: $214 · 2024: $72.43 · 2025: $19.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $433.33 | 2022 | |
| Genzyme Corporation | $110.00 | 2019 | |
| Abbvie INC. | $84.10 | 2023-2024 | |
| Novo Nordisk INC | $49.37 | 2023-2024 | Ozempic, Rybelsus |
| Ethicon INC. | $37.92 | 2023 | Monarch Platform |
| Astrazeneca Pharmaceuticals LP | $28.24 | 2023 | Farxiga, Breztri |
| Exact Sciences Corporation | $22.28 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $19.79 | 2025 | Shingrix |
| Hologic Sales and Service, LLC | $17.51 | 2023 | Aptima |
| Pfizer INC. | $16.94 | 2023 | |
| Amgen INC. | $16.43 | 2023 | Evenity |
| Viiv Healthcare Company | $16.19 | 2022 | |
| Lilly USA, LLC | $15.33 | 2022 | |
| Organon LLC | $13.56 | 2023 | Nexplanon |
| Abbott Laboratories | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameera Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.